November 17, 2022 IntegriChain Partners with PurpleLab to Enhance Pharmaceutical Channel Data for More Accurate GTN Forecasting and Accruals IntegriChain will incorporate PurpleLab prescription drug claims data to address challenges in visibility to demand and inventory that has resulted from evolving pharmaceutical channels for new specialty pharmaceutical products.
November 7, 2022 IntegriChain GTN Experts to Speak at Informa’s Pharma | BioTech GTN Summit IntegriChain is a sponsor of the hybrid conference, which runs November 15 to 17 in Philadelphia. Jen Sharpe, Jeff Baab, and Corne Smal will present 3 sessions on the Inflation Reduction Act, Commercial Launch and GTN materiality.
October 25, 2022 IntegriChain Presents Annual Customer Awards to Cytokinetics, Sebela, Boehringer Ingelheim, and Alkermes We presented our annual customer awards to innovators and visionaries in market access and commercialization. The company awards included Market Access Visionary Award to Cytokinetics, Lighthouse Award for Innovation to Sebela Pharmaceuticals, and the Patient and Channel Data Trailblazer to Boehringer Ingelheim. An individual award, the ICyte Power User Award, was presented to Jim Delaney, Senior Director, National Channel Accounts at Alkermes.
October 17, 2022 Access Insights Conference 2022 Breaks In-Person Attendance Records Access Insights Conference 2022, now co-hosted by Blue Fin Group, broke in-person attendance records. The conference opens today at the Marriott Baltimore Waterfront.
October 3, 2022 IntegriChain Medicaid Pricing Experts to Speak at MDRP Two Contracts & Pricing experts will present at Informa’s upcoming Medicaid Drug Rebate Program (MDRP) conference on digital pharmacy models and the value-based purchasing final rule. IntegriChain is a sponsor of the conference, which runs in person October 12 - 14, 2022.
July 6, 2022 Blue Fin Group Presents Market Research Study on Current and Future Payer Management in Oncology Blue Fin Group today announced a new market research study video assessing current and future payer management in oncology including influences on payer decision-making to prefer drugs in oncology, top barriers and influencers to manage oncolytics, and oncology management expectations in the next three years, including increasing contracting for preference and value-based contracting.
June 23, 2022 Blue Fin Group Releases Explanatory Video on Impacts and Future of Public Health Service 340B Program Blue Fin Group announced the availability of an in-depth video by Principal Consultant Timothy Paine that explores the Public Health Service 340B program, its evolution over 30 years, and what is expected in the coming decade.
May 11, 2022 IntegriChain Pharma Contracts & Pricing Experts to Speak at Upcoming Conferences Four IntegriChain Contracts & Pricing experts will speak at two upcoming conferences: the Medicaid and Government Pricing Congress, being held in person May 23-25 and virtually June 1-2, and the Life Sciences Commercial Contracts and Chargebacks Conference, being held as a hybrid event May 24-25.
April 20, 2022 Registration Opens for Access Insights Conference 2022 IntegriChain opens registration to all pharma manufacturers for the Access Insights Conference 2022, now co-hosted by Blue Fin Group, an IntegriChain Company. The Access Insights Conference will be held October 17-19, 2022, at the Marriott Baltimore Harborside. Designed for commercial, operational, and financial teams at pharma manufacturers, the conference will feature industry executive and practitioner panels, exclusive ICyte Benchmarks presentations, and strategic and tactical programs focused on driving patient access and therapy commercialization.
